Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 of Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting

NCT01255852 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT01255852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01255852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 of Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting
Lead sponsor
Jinling Hospital, China
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2011
Completion date
July 31, 2015
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cvd